ARTICLE SUMMARY:
While venture capital investment in medical devices has stabilized recently, the previous precipitous decline hit the early-stage deal segment the hardest. A few stalwarts remain, however.
Historically, medical device start-ups have feared the so-called Valley of Death, where venture funding to bridge companies from early to later stage has been hard to come by.
